Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS
· Delayed Price · Currency is USD
2.990
+0.240 (8.73%)
Dec 24, 2024, 9:30 AM EST
HRGN Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.24 | 0.1 | - | - | - | - | Upgrade
|
| Revenue Growth (YoY) | 487.50% | - | - | - | - | - | Upgrade
|
| Cost of Revenue | 0.11 | 0.02 | - | - | - | - | Upgrade
|
| Gross Profit | 0.13 | 0.08 | - | - | - | - | Upgrade
|
| Selling, General & Admin | 5.2 | 6.08 | 4.4 | 7.12 | 3.33 | 4.09 | Upgrade
|
| Research & Development | 2.62 | 2.99 | 1.67 | 1.52 | 1.99 | 4.78 | Upgrade
|
| Operating Expenses | 7.82 | 9.07 | 6.07 | 8.64 | 5.33 | 8.87 | Upgrade
|
| Operating Income | -7.69 | -8.99 | -6.07 | -8.64 | -5.33 | -8.87 | Upgrade
|
| Interest Expense | -0.04 | -0.01 | -0.01 | - | - | - | Upgrade
|
| Interest & Investment Income | 0.01 | 0.06 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0.01 | 0 | 0.25 | 0.46 | 0.54 | Upgrade
|
| EBT Excluding Unusual Items | -7.71 | -8.95 | -6.07 | -8.39 | -4.87 | -8.33 | Upgrade
|
| Other Unusual Items | -0.5 | - | - | 0.41 | - | - | Upgrade
|
| Pretax Income | -8.21 | -8.95 | -6.07 | -7.98 | -4.87 | -8.33 | Upgrade
|
| Net Income | -8.21 | -8.95 | -6.07 | -7.98 | -4.87 | -8.33 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 0.08 | 0.18 | - | - | - | Upgrade
|
| Net Income to Common | -8.21 | -9.02 | -6.25 | -7.98 | -4.87 | -8.33 | Upgrade
|
| Shares Outstanding (Basic) | 14 | 13 | 11 | 10 | 9 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 13 | 11 | 10 | 9 | 7 | Upgrade
|
| Shares Change (YoY) | 10.62% | 18.56% | 12.79% | 14.43% | 27.48% | 54.56% | Upgrade
|
| EPS (Basic) | -0.57 | -0.67 | -0.55 | -0.79 | -0.55 | -1.21 | Upgrade
|
| EPS (Diluted) | -0.57 | -0.67 | -0.55 | -0.79 | -0.55 | -1.21 | Upgrade
|
| Free Cash Flow | -4.95 | -6.95 | -5.11 | -2.63 | -4.05 | -6.19 | Upgrade
|
| Free Cash Flow Per Share | -0.35 | -0.52 | -0.45 | -0.26 | -0.46 | -0.90 | Upgrade
|
| Gross Margin | 54.89% | 76.70% | - | - | - | - | Upgrade
|
| Operating Margin | -3271.91% | -8728.16% | - | - | - | - | Upgrade
|
| Profit Margin | -3495.32% | -8759.22% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -2104.26% | -6747.57% | - | - | - | - | Upgrade
|
| EBITDA | -7.67 | -8.96 | -6.01 | -8.53 | -5.14 | -8.66 | Upgrade
|
| D&A For EBITDA | 0.02 | 0.04 | 0.05 | 0.11 | 0.18 | 0.21 | Upgrade
|
| EBIT | -7.69 | -8.99 | -6.07 | -8.64 | -5.33 | -8.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.